HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA "radical reform" bill will be ready in House by January, Gingrich predicts.

This article was originally published in The Rose Sheet

Executive Summary

HOUSE FDA REFORM BILL SHOULD BE READY FOR JANUARY CONSIDERATION, predicts House Speaker Newt Gingrich (R-GA). In a presen-tation to a Sept. 12 legislative briefing sponsored by the Washington law firm of Hogan & Hartson, Gingrich was asked about the prospects for an FDA bill in the crowded legislative schedule. The speaker responded that he expects to see a proposal for "radical reform" by January of next year. That schedule assumes that separate proposals such as a bill specific to medical device reform (HR 2290, introduced on Sept. 8) can be melded with other proposals for drug reform.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002022

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel